Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$5.05 - $10.0 $278,830 - $552,140
-55,214 Reduced 45.53%
66,044 $601,000
Q4 2023

Feb 02, 2024

SELL
$1.65 - $6.85 $85,696 - $355,768
-51,937 Reduced 29.99%
121,258 $725,000
Q3 2023

Oct 27, 2023

SELL
$1.55 - $3.34 $10 - $23
-7 Reduced -0.0%
173,195 $322,000
Q2 2023

Aug 07, 2023

BUY
$3.0 - $3.98 $519,606 - $689,343
173,202 New
173,202 $569,000

Others Institutions Holding SERA

About SERA PROGNOSTICS, INC.


  • Ticker SERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 29,596,900
  • Market Cap $201M
  • Description
  • Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...
More about SERA
Track This Portfolio

Track Acuitas Investments, LLC Portfolio

Follow Acuitas Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuitas Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuitas Investments, LLC with notifications on news.